Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 154

1.

14-3-3ε and 14-3-3σ inhibit Toll-like receptor (TLR)-mediated proinflammatory cytokine induction.

Butt AQ, Ahmed S, Maratha A, Miggin SM.

J Biol Chem. 2012 Nov 9;287(46):38665-79. doi: 10.1074/jbc.M112.367490. Epub 2012 Sep 14.

PMID:
22984265
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

TRIF-mediated TLR3 and TLR4 signaling is negatively regulated by ADAM15.

Ahmed S, Maratha A, Butt AQ, Shevlin E, Miggin SM.

J Immunol. 2013 Mar 1;190(5):2217-28. doi: 10.4049/jimmunol.1201630. Epub 2013 Jan 30.

PMID:
23365087
[PubMed - indexed for MEDLINE]
Free Article
3.

Absence of MyD88 results in enhanced TLR3-dependent phosphorylation of IRF3 and increased IFN-β and RANTES production.

Siednienko J, Gajanayake T, Fitzgerald KA, Moynagh P, Miggin SM.

J Immunol. 2011 Feb 15;186(4):2514-22. doi: 10.4049/jimmunol.1003093. Epub 2011 Jan 19.

PMID:
21248248
[PubMed - indexed for MEDLINE]
Free Article
4.

TLR3-mediated IFN-β gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like.

Siednienko J, Halle A, Nagpal K, Golenbock DT, Miggin SM.

Eur J Immunol. 2010 Nov;40(11):3150-60. doi: 10.1002/eji.201040547. Epub 2010 Oct 19.

PMID:
20957750
[PubMed - indexed for MEDLINE]
5.

Modulation of TLR3, TLR4 and TLR7 mediated IFN-β, Rantes and TNFα production by HIVEP1.

Butt AQ, Miggin SM.

J Biol Chem. 2014 Apr 9. [Epub ahead of print]

PMID:
24719322
[PubMed - as supplied by publisher]
Free Article
6.

Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists.

Figueiredo MD, Vandenplas ML, Hurley DJ, Moore JN.

Vet Immunol Immunopathol. 2009 Jan 15;127(1-2):125-34. doi: 10.1016/j.vetimm.2008.09.028. Epub 2008 Oct 11.

PMID:
19019456
[PubMed - indexed for MEDLINE]
7.

Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex.

Youn HS, Lee JY, Fitzgerald KA, Young HA, Akira S, Hwang DH.

J Immunol. 2005 Sep 1;175(5):3339-46.

PMID:
16116226
[PubMed - indexed for MEDLINE]
Free Article
8.

IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29.

Sirén J, Pirhonen J, Julkunen I, Matikainen S.

J Immunol. 2005 Feb 15;174(4):1932-7.

PMID:
15699120
[PubMed - indexed for MEDLINE]
Free Article
10.

TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain.

Kawamoto T, Ii M, Kitazaki T, Iizawa Y, Kimura H.

Eur J Pharmacol. 2008 Apr 14;584(1):40-8. doi: 10.1016/j.ejphar.2008.01.026. Epub 2008 Feb 5.

PMID:
18299127
[PubMed - indexed for MEDLINE]
11.

Identification and functional characterization of 14-3-3 in TLR2 signaling.

Schuster TB, Costina V, Findeisen P, Neumaier M, Ahmad-Nejad P.

J Proteome Res. 2011 Oct 7;10(10):4661-70. doi: 10.1021/pr200461p. Epub 2011 Aug 26.

PMID:
21827211
[PubMed - indexed for MEDLINE]
12.

Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages.

Xu H, An H, Hou J, Han C, Wang P, Yu Y, Cao X.

Mol Immunol. 2008 Aug;45(13):3545-52. doi: 10.1016/j.molimm.2008.05.006. Epub 2008 Jun 20.

PMID:
18571728
[PubMed - indexed for MEDLINE]
13.

PKC-alpha controls MYD88-dependent TLR/IL-1R signaling and cytokine production in mouse and human dendritic cells.

Langlet C, Springael C, Johnson J, Thomas S, Flamand V, Leitges M, Goldman M, Aksoy E, Willems F.

Eur J Immunol. 2010 Feb;40(2):505-15. doi: 10.1002/eji.200939391.

PMID:
19950169
[PubMed - indexed for MEDLINE]
14.

Dual regulation of osteopontin production by TLR stimulation in dendritic cells.

Salvi V, Scutera S, Rossi S, Zucca M, Alessandria M, Greco D, Bosisio D, Sozzani S, Musso T.

J Leukoc Biol. 2013 Jul;94(1):147-58. doi: 10.1189/jlb.0412194. Epub 2013 Apr 22.

PMID:
23610145
[PubMed - indexed for MEDLINE]
Free Article
15.

Notch signal suppresses Toll-like receptor-triggered inflammatory responses in macrophages by inhibiting extracellular signal-regulated kinase 1/2-mediated nuclear factor κB activation.

Zhang Q, Wang C, Liu Z, Liu X, Han C, Cao X, Li N.

J Biol Chem. 2012 Feb 24;287(9):6208-17. doi: 10.1074/jbc.M111.310375. Epub 2011 Dec 28.

PMID:
22205705
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway.

Lang T, Lo C, Skinner N, Locarnini S, Visvanathan K, Mansell A.

J Hepatol. 2011 Oct;55(4):762-9. doi: 10.1016/j.jhep.2010.12.042. Epub 2011 Feb 18.

PMID:
21334391
[PubMed - indexed for MEDLINE]
17.

Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling.

Piao W, Song C, Chen H, Diaz MA, Wahl LM, Fitzgerald KA, Li L, Medvedev AE.

J Leukoc Biol. 2009 Oct;86(4):863-75. doi: 10.1189/jlb.0309189. Epub 2009 Aug 5.

PMID:
19656901
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Inhibitors of MyD88-dependent proinflammatory cytokine production identified utilizing a novel RNA interference screening approach.

Cho JS, Kim YC, Morrison SL.

PLoS One. 2009 Sep 15;4(9):e7029. doi: 10.1371/journal.pone.0007029.

PMID:
19753301
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.

Jiang Z, Mak TW, Sen G, Li X.

Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3533-8. Epub 2004 Feb 24.

PMID:
14982987
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Heterotrimeric Gi/Go proteins modulate endothelial TLR signaling independent of the MyD88-dependent pathway.

Dauphinee SM, Voelcker V, Tebaykina Z, Wong F, Karsan A.

Am J Physiol Heart Circ Physiol. 2011 Dec;301(6):H2246-53. doi: 10.1152/ajpheart.01194.2010. Epub 2011 Sep 23.

PMID:
21949112
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk